Target intelligence / Profile preview

Peptidoglycan and lipoteichoic acid (PGN and LTA)

Target
PGN and LTA
Molecular classification
Bacterial cell wall component, Pathogen-associated molecular pattern (PAMP), Glycopolymer, Polysaccharide-peptide complex
01

Overview

Peptidoglycan (PGN) and lipoteichoic acid (LTA) are the primary structural and functional constituents of the Gram-positive bacterial cell wall. Peptidoglycan is a complex heteropolymer of sugars and amino acids that forms a mesh-like layer, providing the cell with essential structural integrity and protection against high internal osmotic pressure (Schleifer & Kandler, 1972). Lipoteichoic acid is a surface-associated glycerolphosphate polymer anchored to the plasma membrane that plays critical roles in regulating autolytic enzymes, maintaining ion homeostasis, and facilitating biofilm formation (Percy & Gründling, 2014). These molecules are recognized by the host's innate immune system as pathogen-associated molecular patterns (PAMPs) through pattern recognition receptors like Toll-like receptor 2 (TLR2) and NOD-like receptors, which initiate inflammatory signaling cascades (Kang et al., 2009). Clinically, these components are the direct targets of several potent antibiotic classes; for example, glycopeptides such as vancomycin bind to the D-alanyl-D-alanine terminus of peptidoglycan precursors to prevent cross-linking, while lipopeptides like daptomycin are thought to interact with lipoteichoic acid to facilitate membrane insertion and subsequent depolarization (Bayer et al., 2013). Excessive release of PGN and LTA during severe infections can lead to systemic inflammatory response syndrome and septic shock (Ginsburg, 2002).

Other names
Bacterial cell wall componentsMureinGram-positive cell wall polymersPathogen-associated molecular patterns
02

Mechanism of action

Inhibition of cell wall synthesis by binding to peptidoglycan precursors (D-Ala-D-Ala); disruption of bacterial cell membrane potential through interaction with lipoteichoic acid and membrane lipids; enzymatic hydrolysis of glycan bonds.

03

Biological functions

Structural integrityOsmotic protectionImmune response activationIon homeostasisCell division regulationBiofilm formation
04

Disease associations

InfectionSepsisSeptic shockInflammation
05

Safety considerations

Antibiotic resistance (e.g., VRE, VRSA)NephrotoxicityJarisch-Herxheimer reactionInfusion-related reactions (Red Man Syndrome)Myopathy
06

Interacting drugs

Vancomycin

8 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive proteinSoluble CD14Interleukin-6

Beyond the preview

Go deeper on Peptidoglycan and lipoteichoic acid (PGN and LTA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidoglycan and lipoteichoic acid (PGN and LTA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call